APA (7th ed.) Citation

Greten, T. F., Forner, A., Korangy, F., N'Kontchou, G., Barget, N., Ayuso, C., . . . Bruix, J. (2010). A phase II open label trial evaluating safety andefficacy of a telomerase peptide vaccination inpatients with advanced hepatocellular carcinoma. BMC Cancer, 10, 209. https://doi.org/10.1186/1471-2407-10-209

Chicago Style (17th ed.) Citation

Greten, Tim F., et al. "A Phase II Open Label Trial Evaluating Safety Andefficacy of a Telomerase Peptide Vaccination Inpatients with Advanced Hepatocellular Carcinoma." BMC Cancer 10 (2010): 209. https://doi.org/10.1186/1471-2407-10-209.

MLA (9th ed.) Citation

Greten, Tim F., et al. "A Phase II Open Label Trial Evaluating Safety Andefficacy of a Telomerase Peptide Vaccination Inpatients with Advanced Hepatocellular Carcinoma." BMC Cancer, vol. 10, 2010, p. 209, https://doi.org/10.1186/1471-2407-10-209.